Search clinical trials for: Belantamab Mafodotin
Total 66 results
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
Medical University of ViennaNot yet recruitingMultiple Myeloma | Corneal Diseases | Corneal Cyst
-
M.D. Anderson Cancer CenterRecruiting
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
European Myeloma NetworkGlaxoSmithKlineRecruitingAL AmyloidosisGermany, Netherlands, France, Greece, Italy, United Kingdom
-
Medical College of WisconsinRecruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
University of PennsylvaniaGlaxoSmithKlineRecruiting
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Greece, Korea, Republic of, Singapore
-
Jacob Soumerai, MDGlaxoSmithKlineRecruitingRelapsed Plasmablastic Lymphoma | Refractory Plasmablastic Lymphoma | Anaplastic Lymphoma Kinase Positive Large B-Cell LymphomaUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Spain, France, Germany, Australia, United Kingdom, Canada, Italy
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
GlaxoSmithKlineTerminatedMultiple MyelomaUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Italy, Poland, Spain, Taiwan, Brazil, Greece, Ireland, Mexico, Canada, Korea, Republic of, Germany, France, Australia, United Kingdom, Argentina, India, Thailand, Switzerland
-
Fondazione EMN Italy OnlusRecruiting
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineRecruitingMultiple MyelomaGreece, Korea, Republic of, United States
-
Janssen Research & Development, LLCWithdrawnRelapsed/ Refractory Multiple MyelomaUnited States, Poland
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Hellenic Society of HematologyGlaxoSmithKlineActive, not recruiting
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Universitätsklinikum Hamburg-EppendorfRecruitingMultiple Myeloma | Multiple Myeloma in RelapseGermany
-
GlaxoSmithKlineAvailable
-
GlaxoSmithKlineMerck Sharp & Dohme LLCCompletedMultiple MyelomaSpain, Germany, United States, Canada
-
M.D. Anderson Cancer CenterRecruiting
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Poland, Taiwan, Korea, Republic of, Japan, United Kingdom, Brazil, Mexico, Turkey, Argentina
-
PETHEMA FoundationAdknoma Health ResearchRecruitingRelapsed Multiple MyelomaSpain
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCWithdrawnMultiple Myeloma, RefractoryUnited States
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Wake Forest University Health SciencesGlaxoSmithKline; AmgenActive, not recruitingMultiple MyelomaUnited States
-
GlaxoSmithKlineActive, not recruiting
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, Italy, Japan, Poland, Spain, United Kingdom, France, Germany, Greece, Canada, China, Israel, Korea, Republic of, Brazil, Russian Federation, Czechia, New Zealand, Turkey
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic DiseaseGreece
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ROS1 Gene Rearrangement | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | ALK PositiveUnited States
-
Mayo ClinicRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
University of ChicagoGlaxoSmithKline; AmgenRecruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States
-
Hellenic Society of HematologyGlaxoSmithKlineNot yet recruitingNeoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Multiple Myeloma in Relapse | Gammopathy, Monoclonal | Haematologic Disease
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Not yet recruitingRefractory Multiple Myeloma | Recurrent Multiple Myeloma
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic Disease | Neoplasm, Plasma CellGreece
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
-
Emory UniversityNational Cancer Institute (NCI); GlaxoSmithKlineRecruitingPlasma Cell MyelomaUnited States
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States